hotspot -WSS

hotspot

author：comprehensive 2025-09-30 17:04:12 - browse：94

A Medicare health insurance card on top of several hundred-dollar bills, with Benjamin Franklin's eyes covered by pills. — Adobe

The public will soon find out whether the federal government is willing to meet the health insurance industry’s demands and deposit more money into the bank accounts of next year’s Medicare Advantage plans.

Budget officials within the Biden administration started reviewing final payment regulations for 2025 Medicare Advantage plans last week after more than 42,000 public comments rolled into the federal government’s inbox. Those rules will come out no later than April 1.

In February, the government proposed a modest cut to next year’s average benchmark payment for Medicare Advantage plans, which are privately run insurance policies that now cover more than 33 million Americans. However, insurers are still estimated to receive more money under the proposal, overall, due to the aggressive way they code the medical conditions of their members.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Mark Cuban is blaming the wrong people for high drug costs

knowledge

WSS

Aspartame and sugar

Aspartame and sugar

Be careful with at

What will Novo Nordisk's VC do with its influx of cash?

Surge in Apellis stock fueled by confidence in safety of its eye drug

Idaho college killings prosecutors challenge defense's grand jury claims

explore

hotspot

focus

Activists slam private health insurers over coverage restrictions

IVG is promising — but it won’t replace IVF quite yet

New air purifier tech could be key to improving indoor air quality

The biotech scorecard for Q4: 16 stock

Duchenne breakthrough therapy leaves behind pioneering families

Will an HIV vaccine ever be a reality?

At least 13 dead in Texas as scorching temps continue

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Mark Cuban is blaming the wrong people for high drug costs

leisure time

The Karikó problem: Lessons for funding basic research

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

What to know about the judge who will handle the Trump case

IVG is promising — but it won’t replace IVF quite yet

Indictment alleges Trump's ex

Judge sides with young activists in first

entertainment

knowledge

knowledge

hotspot